Document Actions
Life Sciences Center Amsterdam
The Life Sciences Center Amsterdam is your point of entry to innovative technologies from: Academical Medical Center Amsterdam (AMC), University of Amsterdam (UvA), VU University & VU University medical center (VU & VUmc), Sanquin and Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital (NKI-AvL).
The opportunities listed are available for technology transfer. If you require further information on any of them, please contact the LSCA office or contact Prof. Dr. Ada Kruisbeek, Director Life Sciences Center Amsterdam at kruisbeek@tto.vu.nl or Drs. Robert Jan Lamers, Associate Director Life Sciences Center Amsterdam at r.j.lamers@uva.nl.
Contact information:
Ingrid van Es
Office Manager Life Sciences Center Amsterdam (LSCA)
Science Park 402
1098 XH Amsterdam
T +31 (0)20 525 2092
E y.t.vanes@lscamsterdam.nl or info@lscamsterdam.nl
Licensing Opportunities
Medical devices & materials
| Adaptive Filter | AMC |
| Biological Pacemaker | AMC |
| Improved depth perception | AMC |
Gene targets & Molecular diagnostics
| Pruritus | AMC |
| Restenosis risk assessment | AMC |
| Vulnerable Plaques | AMC |
Disease & Therapy
| Anti-inflammatory pro-drugs | AMC |
| Arteriogenesis | AMC |
| Biological Pacemaker | AMC |
| DIMS | AMC |
| HIV env vaccine | AMC |
| Hobit | AMC |
| Master gene Arteriogenesis | AMC |
| miR treatment of fibrosis | AMC |
| Improved treatment of cancer by means of combination therapy | AMC |
| DIY low complexity RNAi libraries | Netherlands Cancer Institute |
Screening & detection
| Netherlands Cancer Institute |
Research Tools
| Booster immune response | AMC |
| Mouse with human immune system | AMC |
| Novel liposomal formulation for enhanced doxorubicine uptake | Netherlands Cancer Institute |
Life Sciences brochure: link